Muscarinic M5 acetylcholine receptor (M5R or CHRM5)-expressing neurons represent a distinct neuronal population characterized by high expression of the M5 subtype of muscarinic cholinergic receptors. These neurons are distributed throughout the central nervous system, with particularly prominent populations in the striatum, midbrain dopaminergic regions, prefrontal cortex, and hippocampus. The M5R belongs to the family of G-protein coupled receptors (GPCRs) and is encoded by the CHRM5 gene located on chromosome 15q26 in humans. M5R-expressing neurons play critical roles in motor control, reward processing, attention, and learning, making them essential contributors to cognitive and motor function. The selective vulnerability of certain M5R-expressing neuronal populations in neurodegenerative diseases has emerged as an important research focus in understanding disease pathogenesis.
Function/Biology
...
Muscarinic M5 Acetylcholine Receptor Neurons
Overview
Muscarinic M5 acetylcholine receptor (M5R or CHRM5)-expressing neurons represent a distinct neuronal population characterized by high expression of the M5 subtype of muscarinic cholinergic receptors. These neurons are distributed throughout the central nervous system, with particularly prominent populations in the striatum, midbrain dopaminergic regions, prefrontal cortex, and hippocampus. The M5R belongs to the family of G-protein coupled receptors (GPCRs) and is encoded by the CHRM5 gene located on chromosome 15q26 in humans. M5R-expressing neurons play critical roles in motor control, reward processing, attention, and learning, making them essential contributors to cognitive and motor function. The selective vulnerability of certain M5R-expressing neuronal populations in neurodegenerative diseases has emerged as an important research focus in understanding disease pathogenesis.
Function/Biology
M5R-expressing neurons function as modulatory elements within multiple neural circuits. In the striatum, these neurons include a subset of GABAergic medium spiny neurons and cholinergic interneurons that regulate motor output through their connections with dopaminergic systems. M5R activation increases intracellular calcium and enhances neuronal excitability through Gq/11 G-protein coupling, facilitating acetylcholine-mediated neurotransmission. These neurons are particularly important in motivation and reward-related behaviors, as they extensively innervate ventral tegmental area dopaminergic neurons that project to nucleus accumbens and prefrontal cortex. M5R-expressing pyramidal neurons in the prefrontal cortex contribute to executive function and working memory through their modulation of local circuit activity and long-range projections to striatal and limbic structures. The M5R subtype exhibits relatively higher affinity for acetylcholine compared to some other muscarinic subtypes and shows unique coupling to phospholipase C signaling cascades. These neurons express characteristic electrophysiological properties including moderate spontaneous firing rates and responsiveness to cholinergic agonists, which enhances their firing frequency and synaptic transmission.
Role in Neurodegeneration
M5R-expressing neurons demonstrate selective vulnerability in multiple neurodegenerative conditions, particularly Parkinson's disease, Alzheimer's disease, and Huntington's disease. In Parkinson's disease, dysfunction of striatal M5R-containing neurons contributes to motor complications and dopaminergic dysregulation. Studies indicate that cholinergic-dopaminergic imbalance in the striatum, involving altered M5R signaling, exacerbates parkinsonian symptoms and motor fluctuations during disease progression. In Alzheimer's disease, M5R-expressing neurons in the hippocampus and cortex show functional impairment related to accumulated amyloid-beta and phosphorylated tau pathology, contributing to cognitive decline and memory deficits. The cholinergic system's broader dysfunction in Alzheimer's disease has long been recognized, and M5R neurons represent a significant component of this pathology. In Huntington's disease, huntingtin protein aggregates preferentially affect striatal neurons expressing M5R and other cholinergic markers, leading to progressive motor and cognitive decline.
Molecular Mechanisms
The vulnerability of M5R-expressing neurons involves multiple molecular pathways. Amyloid-beta oligomers directly impair M5R signaling through disruption of G-protein coupling and calcium homeostasis, reducing neuroprotective signaling. Phosphorylated tau accumulation in M5R-expressing neurons impairs axonal transport and synaptic function. Dopaminergic denervation in Parkinson's disease alters the balance of muscarinic and dopaminergic receptor signaling, causing compensatory upregulation or downregulation of M5R expression. Oxidative stress and mitochondrial dysfunction preferentially affect M5R neurons due to their high metabolic demand and extensive dendritic arborization. Additionally, altered acetylcholine synthesis and vesicular packaging impairs M5R activation in degenerating cholinergic systems, reducing neuroprotective signaling through phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways.
Clinical/Research Significance
Understanding M5R neuron dysfunction offers therapeutic opportunities in neurodegenerative disease treatment. M5R-selective agonists show potential for enhancing cognitive function in Alzheimer's disease and improving motor symptoms in Parkinson's disease. Research using optogenetic manipulation of M5R-expressing neurons in animal models has demonstrated their critical role in motor control and motivation. Biomarkers reflecting M5R neuron function, such as altered cerebrospinal fluid acetylcholine levels and imaging studies of cholinergic denervation, may assist in early disease detection and monitoring.
The following diagram shows the key molecular relationships involving Muscarinic M5 Acetylcholine Receptor Neurons discovered through SciDEX knowledge graph analysis: